Loading...
Therapeutic advances in the management of Pompe disease and other metabolic myopathies
The world of metabolic myopathies has been dramatically modified by the advent of enzyme replacement therapy (ERT), the first causative treatment for glycogenosis type II (GSDII) or Pompe disease, which has given new impetus to research into that disease and also other pathologies. This article revi...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
SAGE Publications
2013
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3755530/ https://ncbi.nlm.nih.gov/pubmed/23997816 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756285613487570 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|